Drugs / IFN-α
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT00559026 Comparator | Sep 2004 → Sep 2006 | melanoma | Italian National Institute of Health | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | IFN-α | “s.c. injection of 3MU IFN-α, as an adjuvant” NCT00559026 ↗ |
| Route | Subcutaneous | “s.c. injection of 3MU IFN-α” NCT00559026 ↗ |